Search Within

Neil Vasan

  1. "MSK Grad Students"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (4)
Groups
  1. Breast Medicine Service (9)
  2. Department of Medicine (9)
  3. GSK Faculty (9)
  4. MSK Grad Students (9)
  5. Sloan Kettering Institute Postdocs (9)
  6. Solid Tumor Oncology Division (9)

More Groups

People
  1. Maurizio Scaltriti (8)
  2. Alexander Gorelick (7)
  3. Barry Taylor (7)
  4. Eneda Toska (6)
  5. Eduard Reznik (5)
  6. Guotai Xu (5)

More People

Years
  1. 2021 (2)
  2. 2020 (4)
  3. 2019 (2)
  4. 2018 (1)
Publications
  1. Cancer Research (3)
  2. Cancer Discovery (2)
  3. Cancer Cell (1)
  4. Molecular Cancer Research (1)
  5. Nature (1)
  6. Science (1)
Publishers
  1. American Association for Cancer Research (6)
  2. American Association for the Advancement of Science (1)
  3. Cell Press (1)
  4. Nature Publishing Group (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Metastasis and immune evasion from extracellular cGAMP hydrolysis
    Journal Article

    Li, J.; Duran, M. A.; Dhanota, N.; Chatila, W. K.; Bettigole, S. E.; Kwon, J.; Sriram, R. K.; Humphries, M. P.; Salto-Tellez, M.; James, J. A.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • TRK XDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Journal Article

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arruabarrena-Aristorena, A.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
    Meeting Abstract

    Vasan, N.; Razavi, P.; Johnson, J. L.; Shao, H.; Shah, H.; Antoine, A.; Ladewig, E.; Gorelick, A.; Lin, T. Y.; Toska, E.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Meeting Abstract

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arena, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Compound PIK3CA mutations support a mutational dose-response model for oncogene activation and response to PI3K inhibitor targeted therapy in breast cancer
    Meeting Abstract

    Vasan, N.; Johnson, J.; Shao, H.; Razavi, P.; Gorelick, A.; Ladewig, E.; Antoine, A.; Shah, H.; Toska, E.; Xu, G.; more...
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • Phase and context shape the function of composite oncogenic mutations
    Journal Article

    Gorelick, A. N.; Sánchez-Rivera, F. J.; Cai, Y.; Bielski, C. M.; Biederstedt, E.; Jonsson, P.; Richards, A. L.; Vasan, N.; Penson, A. V.; Friedman, N. D.; more...
    Nature (2020)

    Fulltext@MSK | Save
  • Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Ka inhibitors
    Journal Article

    Vasan, N.; Razavi, P.; Johnson, J. L.; Shao, H.; Shah, H.; Antoine, A.; Ladewig, E.; Gorelick, A.; Lin, T. Y.; Toska, E.; more...
    Science (2019)

    Fulltext@MSK | Save
  • Double PIK3CA mutations in cis enhance oncogene activation and sensitivity to PI3K alpha inhibitors in breast cancer
    Meeting Abstract

    Vasan, N.; Razavi, P.; Johnson, J.; Shao, H.; Shah, H.; Antoine, A.; Ladewig, E.; Gorelick, A.; Toska, E.; Xu, G.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • The genomic landscape of endocrine-resistant advanced breast cancers
    Journal Article

    Razavi, P.; Chang, M. T.; Xu, G.; Bandlamudi, C.; Ross, D. S.; Vasan, N.; Cai, Y.; Bielski, C. M.; Donoghue, M. T. A.; Jonsson, P.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save